DQB1*0301 and DQB1*0601 Modulate Narcolepsy Susceptibility in Koreans

Human Immunology

Volumn 68, Issue 1, 2007, Pages 59-68

  Hong, Seung Chul ^a   Lin, Ling ^b   Lo, Betty ^b   Jeong, Jong Hyun ^a   Shin, Yoon Kyung ^a   Kim, Su Yeon ^a   Kweon, Yongsil ^c   Zhang, Jing ^b   Einen, Mali ^b   Smith, Anajane ^d   Hansen, John ^d   Grumet, F Carl ^b   Mignot, Emmanuel ^b  

^a The Catholic University of Korea   (South Korea)

^b STANFORD UNIVERSITY   (United States)

^c Uijeongbu St Mary's Hospital   (South Korea)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

cataplexy; DQB1*0301; DQB1*0601; DQB1*0602; HLA; hypocretin; Narcolepsy; orexin

Indexed keywords

HLA ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; OREXIN A; HLA DQ ANTIGEN; HLA DQB1 PROTEIN, HUMAN; HLA-DQB1 PROTEIN, HUMAN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALLELISM; ARTICLE; CATAPLEXY; CAUCASIAN; CONTROLLED STUDY; ETHNIC GROUP; EUROPE; EUROPEAN AMERICAN; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; NARCOLEPSY; NORTH AMERICA; PRIORITY JOURNAL; SOMNOLENCE; SOUTH KOREA; GENETICS; KOREA; METABOLISM; PHYSIOLOGY;

GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HUMANS; KOREA; MEMBRANE GLYCOPROTEINS; NARCOLEPSY;

EID: 33845887161     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.10.006     Document Type: Article

References (33)

1. Overeem S., Mignot E., van Dijk J.G., and Lammers G.J. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 18 (2001) 78
2. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed. (2005), American Academy of Sleep Medicine, Westchester
3. Peyron C., Faraco J., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., and Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6 (2000) 991
4. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., and Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 (2000) 469
5. Nishino S., Ripley B., Overeem S., Lammers G.J., and Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (2000) 39
6. Mignot E., Lammers G.J., Ripley B., Okun M., Nevsimalova S., Overeem S., Vankova J., Black J., Harsh J., Bassetti C., Schrader H., and Nishino S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59 (2002) 1553
7. Scammell T.E. The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy. Sleep 29 (2006) 601
8. Black III J.L. Narcolepsy: a review of evidence for autoimmune diathesis. Int Rev Psychiatry 17 (2005) 461
9. Juji T., Satake M., Honda Y., and Doi Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 24 (1984) 316
10. Marcadet A., Gebuhrer L., Betuel H., Seignalet J., Freidel A.C., Confavreux C., Billiard M., Dausset J., and Cohen D. DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy. Immunogenetics 22 (1985) 679
11. Mueller-Eckhardt G., Meier-Ewert K., Schendel D.J., Reinecker F.B., Multhoff G., and Mueller-Eckhardt C. HLA and narcolepsy in a German population. Tissue Antigens 28 (1986) 163
12. Neely S., Rosenberg R., Spire J.P., Antel J., and Arnason B.G. HLA antigens in narcolepsy. Neurology 37 (1987) 1858
13. Lin L, Mignot E: HLA and Narcolepsy: Present Status and Relationship With Familial History and Hypocretin Deficiency. In Bassetti C, Billiard M, Mignot E, (eds): Narcolepsy and Hypersomnia. New York, Marcel Dekker/Taylor & Francis Health Sciences, in press.
14. Matsuki K., Grumet F.C., Lin X., Gelb M., Guilleminault C., Dement W.C., and Mignot E. DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet 339 (1992) 1052
15. Mignot E., Kimura A., Lattermann A., Lin X., Yasunaga S., Mueller-Eckhardt G., Rattazzi C., Lin L., Guilleminault C., Grumet F.C., Mayer G., Dement W.C., and Underhill P. Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 49 (1997) 329
16. Matsuki K., Honda Y., and Juji T. Diagnostic criteria for narcolepsy and HLA-DR2 frequencies. Tissue Antigens 30 (1987) 155
17. Mignot E., Hayduk R., Black J., Grumet F.C., and Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20 (1997) 1012
18. Pelin Z., Guilleminault C., Risch N., Grumet F.C., Mignot E., and US Modafinil in Narcolepsy Multicenter Study Group. HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. Tissue Antigens 51 (1998) 96
19. Mignot E., Lin L., Rogers W., Honda Y., Qiu X., Lin X., Okun M., Hohjoh H., Miki T., Hsu S., Leffell M., Grumet F., Fernandez-Vina M., Honda M., and Risch N. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68 (2001) 686
20. Mignot E, Lin L, Lathrop M, Thorsby E, Tokunaga K, Honda Y, Dauvilliers Y, Tafti M, Billiard M, Mayer G, Montplaisir J, Rouleau G, Temple H, Thorpy M, Martins B, Martins Silva A, Vazquez M, Alaez C, Gorodezky G, Lo B, Grumet FC, Li H, Thomson G, Dorman J, Steenkiste A, Valdes AM, Schoch G, Zhao LP, Smith A, Hansen J: The 13th International Histocompatibility Working Group for Narcolepsy Joint Report. In Hansen J, Dupont B, (eds): HLA 2004: Immunobiology of the Human MHC. Proceedings of the 13th International Histocompatibility Workshop and Congress. Seattle, IHWG Press, in press.
21. Oksenberg J.R., Barcellos L.F., Cree B.A., Baranzini S.E., Bugawan T.L., Khan O., Lincoln R.R., Swerdlin A., Mignot E., Lin L., Goodin D., Erlich H.A., Schmidt S., Thomson G., Reich D.E., Pericak-Vance M.A., Haines J.L., and Hauser S.L. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 74 (2004) 160
22. Thorsby E., and Ronningen K.S. Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus. Ann Med 24 (1992) 523
23. Ghodke Y., Joshi K., Chopra A., and Patwardhan B. HLA and disease. Eur J Epidemiol 20 (2005) 475
24. Marrosu M.G., Murru M.R., Costa G., Murru R., Muntoni F., and Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 7 (1998) 1235
25. Margaritte-Jeannin P., Babron M.C., Bourgey M., Louka A.S., Clot F., Percopo S., Coto I., Hugot J.P., Ascher H., Sollid L.M., Greco L., and Clerget-Darpoux F. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens 63 (2004) 562
26. Hong SC, Lin L, Jeong JH, Shin YK, Han JH, Lee JH, Lee SP, Zhang J, Einen M, Mignot E: A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Sleep: in press.
27. Song E.Y., Park M.H., Kang S.J., Park H.J., Kim B.C., Tokunaga K., Akaza T., and Juji T. HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens 59 (2002) 475
28. Hohjoh H., Terada N., Nakayama T., Kawashima M., Miyagawa T., Honda Y., and Tokunaga K. Case-control study with narcoleptic patients and healthy controls who, like the patients, possess both HLA-DRB1*1501 and -DQB1*0602. Tissue Antigens 57 (2001) 230
29. Lin L., Hungs M., and Mignot E. Narcolepsy and the HLA region. J Neuroimmunol 117 (2001) 9
30. Kwok W.W., Thurtle P., and Nepom G.T. A genetically controlled pairing anomaly between HLA-DQ alpha and HLA-DQ beta chains. J Immunol 143 (1989) 3598
31. Kwok W.W., Kovats S., Thurtle P., and Nepom G.T. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer. J Immunol 150 (1993) 2263
32. Koeleman B.P., Lie B.A., Undlien D.E., Dudbridge F., Thorsby E., de Vries R.R., Cucca F., Roep B.O., Giphart M.J., and Todd J.A. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun 5 (2004) 381
33. Baas A., Gao X., and Chelvanayagam G. Peptide binding motifs and specificities for HLA-DQ molecules. Immunogenetics 50 (1999) 8